Literature DB >> 16094229

Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents.

David P Greenberg1.   

Abstract

As a result of waning immunity and improved awareness, the reported incidence of pertussis is increasing among adolescents in the United States. Symptoms of pertussis are often mild and difficult to diagnose in adolescents, but these individuals can transmit the infection to schoolmates and family members, including high risk infants. Improvements in diagnosis and prevention of pertussis in adolescents are needed.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16094229     DOI： 10.1097/01.inf.0000172905.08606.a3

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  16 in total

1.  Bordetella pertussis IgG and IgA antibodies seroprevalence among 1-35 y-old population: the role of subclinical pertussis infection.

Authors:  Mohammed-Jafar Saffar; Ali-Reza Khalilian; Ali-Reza Rafee; Mohammed Reza Parsaei; Shadi Imanikhani; Jalil Shojaei; Hana Saffar
Journal:  Indian J Pediatr       Date:  2011-11-22       Impact factor: 1.967

2.  How long can we expect pertussis protection to last after the adolescent booster dose of tetanus-diphtheria-pertussis (Tdap) vaccines?

Authors:  Nawaf Al Dajani; David Scheifele
Journal:  Paediatr Child Health       Date:  2007-12       Impact factor: 2.253

3.  Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants.

Authors:  Dana Jaffe; Esperanza B Papadopoulos; James W Young; Richard J O'reilly; Susan Prockop; Nancy A Kernan; Ann Jakubowski; Farid Boulad; Miguel-Angel Perales; Hugo Castro-Malaspina; Trudy N Small
Journal:  Blood       Date:  2006-06-08       Impact factor: 22.113

Review 4.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

5.  The Bordetella Bps polysaccharide is critical for biofilm development in the mouse respiratory tract.

Authors:  Gina Parise Sloan; Cheraton F Love; Neelima Sukumar; Meenu Mishra; Rajendar Deora
Journal:  J Bacteriol       Date:  2007-06-22       Impact factor: 3.490

Review 6.  Protecting Newborns Against Pertussis: Treatment and Prevention Strategies.

Authors:  Abdulbaset M Salim; Yan Liang; Paul E Kilgore
Journal:  Paediatr Drugs       Date:  2015-12       Impact factor: 3.022

7.  [Booster doses outside of the Expanded Program on Immunization in two schools in basic education in Yaounde, Cameroon].

Authors:  Clémence Vougmo Meguejio Njua; Félicitée Nguefack; David Chelo; Mathurin Tejiokem; Innocent Kago; Marie Kobela
Journal:  Pan Afr Med J       Date:  2011-10-12

8.  Detection of Bordetella pertussis in Infants Suspected to have Whooping Cough.

Authors:  Massoud Hajia; Mohammad Rahbar; Fatemeh Fallah; Nooshafarin Safadel
Journal:  Open Respir Med J       Date:  2012-06-15

9.  Estimating the duration of pertussis immunity using epidemiological signatures.

Authors:  Helen J Wearing; Pejman Rohani
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

10.  Immunogenicity and safety results from a randomized multicenter trial comparing a Tdap-IPV vaccine (REPEVAX®) and a tetanus monovalent vaccine in healthy adults: new considerations for the management of patients with tetanus-prone injuries.

Authors:  Henri Laurichesse; Ulrich Zimmermann; Florence Galtier; Odile Launay; Xavier Duval; Patrick Richard; Christine Sadorge; Benoit Soubeyrand
Journal:  Hum Vaccin Immunother       Date:  2012-10-02       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.